Abstract
Cancer of the anus, vulva, and penis are rare diseases. They are associated with human papillomavirus (HPV) infection. HIV-infected patients have a higher risk of developing these cancers in comparison with the general population. Anal, vulvar, and penile cancers are lymphophilic tumors, and lymph node involvement is the most important predictor of prognosis. Surgery with lymph node dissection is the standard treatment of invasive vulvar and penile cancers. Depending on the surgical pathology result following, adjuvant radiotherapy may be indicated. Radiotherapy with or without concurrent chemotherapy is the standard treatment of anal cancer; salvage abdominoperineal resection is indicated in case of local relapse after radiotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59–67
Anal Cancer
National Cancer Institute (2014) Cancer of the anus, anal canal, and anorectum. SEER – Surveillance, Epidemiology, and End Results Program. National Cancer Institute, Bethesda, USA
Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC (2004) Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190(9):1685–1691
Tanum G, Tveit K, Karlsen KO (1991) Diagnosis of anal cancer–doctor’s finger still the best? Oncology 48:383–386
Anal canal (2015) In: American Joint Committee on Cancer. AJCC cancer staging manual, 7th ed.; 2011. Springer, New York, pp 106–109
Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB III, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG (2010) Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98–11). Cancer 116:4007–4013
Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049
Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5- fluorouracil, and mitomycin (1996) Lancet 348:1049–1054
Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid cancer of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539
Shridhar R, Shibata D, Chan E, Thomas CR (2015) Anal cancer: current standards in care and recent changes in practice. CA Cancer J Clin 65(2):139–162
James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell cancer of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol 14:516–524
Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB III, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for cancer of the anal canal: a randomized controlled trial. JAMA 299:1914–1921
Eng C, Pathak P (2008) Treatment options in metastatic squamous cell cancer of the anal canal. Curr Treat Options Oncol 9:400–407
Penile Cancer
Panda K, Nayak CR (1980) Clinicopathological studies on cancer penis (a review of 120 cases). J Indian Med Assoc 75(2):25–28
Moses S, Bailey RC, Ronald AR (1998) Male circumcision: assessment of health benefits and risks. Sex Transm Infect 74(5):368–373
Vulvar Cancer
Forman D, Bray F, Brewster DH et al (2014) Cancer incidence in five continents, vol. X (electronic version) IARC, Lyon. http://ci5.iarc.fr. Accessed 30 Sept 2014
De Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615
Bruni L, Barrionuevo-Rosas L, Serrano B et al (2014) ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in World. Barcelona, Spain. Summary Report 2014-08-22. Accessed 30 Sept 2014
De Sanjosé S, Alemany L, Ordi J et al (2013) Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 49:3450–3461
Del Pino M, Rodriguez-Carunchio L, Ordi J (2013) Pathways of vulvar intraepithelial neoplasia and squamous cell cancer. Histopathology 62(1):161–175
Van der Avoort IA, Shirango H, Hoevenaars BM, Grefte JM, de Hullu JA, de Wilde PC, Bulten J, Melchers WJ, Massuger LF (2006) Vulvar squamous cell cancer is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 25(1):22–29
McCluggage WG (2013) Premalignant lesions of the lower female genital tract: cervix, vagina and vulva. Pathology 45(3):214–228
Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH, Wright RL, D’Souza G, Colie C, Strickler HD, Women’s Interagency HIV Study Collaborative Study Group (2011) Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol 118(4):831–839
Sobin LH, Gospodarowicz MK, Wittekind C (2009) UICC: TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Oxford. ISBN 978-1-4443-3241-4
Pecorelli S (2009) Revised FIGO staging for cancer of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2):103–104
Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V (2006) Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 108(6):1361–1368
Ansink A, van der Velden J (2000) Surgical interventions for early squamous cell cancer of the vulva. Cochrane Database Syst Rev 2, CD002036
Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, Cheung MK, Berman ML, Disaia PJ (2007) Margin distance and other clinico-pathologic prognostic factors in vulvar cancer: a multivariate analysis. Gynecol Oncol 104(3):636–641
Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, Vecchione F, Kusamura S (2006) Clinical and pathological prognostic factors in squamous cell cancer of the vulva. Gynecol Oncol 102(2):333–337
Homesley HD, Bundy BN, Sedlis A et al (1993) Prognostic factors for groin node metastasis in squamous cell cancer of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 49(3):279–283
Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ (2002) Local relapse in patients treated for squamous cell vulvar cancer: incidence and prognostic value. Obstet Gynecol 100(6):1159–1167
Van der Velden J, van Lindert AC, Lammes FB et al (1995) Extracapsular growth of lymph node metastases in squamous cell cancer of the vulva. The impact on recurrence and survival. Cancer 75(12):2885–2890
Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, Hasenburg A, Sehouli J, Habermann A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Thiel F, Mustea A, Meier W, du Bois A, Griebel LF, Woelber L, AGO-CaRE Investigators (2015) Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 Study. J Natl Cancer Inst 107(3):1–12
Parthasarathy A, Cheung MK, Osann K et al (2006) The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar cancer. Gynecol Oncol 103(3):1095–1099
Oonk MH, van Hemel BM, Hollema H et al (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7):646–652
Fons G, Groenen SMA, Oonk MHM et al (2009) Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol 114(2):343–345
Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP (2013) Relationship of margin status and radiation dose to recurrence in post-operative vulvar cancer. Gynecol Oncol 130(3):545–549
Aragona AM, Cuneo NA, Soderini AH, Alcoba EB (2014) An analysis of reported independent prognostic factors for survival in squamous cell cancer of the vulva: is tumor size significance being underrated? Gynecol Oncol 132(3):643–648
Bellati F, Angioli R, Manci N, Angelo Zullo M, Muzii L, Plotti F, Basile S, Panici PB (2005) Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 96(1):227–231
Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM (2000) Chemoradiation as primary or adjuvant treatment for locally advanced cancer of the vulva. Int J Radiat Oncol Biol Phys 47(5):1235–1244
Cunningham MJ, Goyer RP, Gibbons SK, Kredentser DC, Malfetano JH, Keys H (1997) Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous cancer of the vulva. Gynecol Oncol 66(2):258–261
Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK, Homesley HD, Walker JL (2012) A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell cancer of the vulva: a gynecologic oncology group study. Gynecol Oncol 124(3):529–533
Shylasree TS, Bryant A, Howells RE (2011) Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev 13(4):CD003752
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Spano, JP., Moureau-Zabotto, L., Minsat, M., Quéro, L. (2015). Cancer of the Penis, Anus, and Vulva. In: Droz, JP., Carme, B., Couppié, P., Nacher, M., Thiéblemont, C. (eds) Tropical Hemato-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18257-5_45
Download citation
DOI: https://doi.org/10.1007/978-3-319-18257-5_45
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18256-8
Online ISBN: 978-3-319-18257-5
eBook Packages: MedicineMedicine (R0)